The demo obtained the two its Major endpoints, with semaglutide two.4 mg demonstrating statistically substantial and top-quality advancements in liver fibrosis without having worsening of steatohepatitis, and resolution of steatohepatitis without having worsening of liver fibrosis in individuals with MASH as compared to placebo.1Inform your doctor … Read More